PolyPid reports positive phase 3 surgical infection drug trial
Israeli late-stage biopharmaceutical company PolyPid (Nasdaq: PYPD) has reported positive Phase III trial results on its treatment for surgical ...
Monday, January 12, 2026
Tag: PolyPid
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.